IP Verse

Stabilized Modified Release Vitamin D Formulation And Method Of Administring Same - EP2968172

The patent EP2968172 was granted to Eirgen Pharma on Oct 7, 2020. The application was originally filed on Mar 14, 2014 under application number EP14717038A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2968172

EIRGEN PHARMA
Application Number
EP14717038A
Filing Date
Mar 14, 2014
Status
Granted And Under Opposition
Jun 19, 2020
Publication Date
Oct 7, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

DSM NUTRITIONAL PRODUCTSApr 21, 2021KRAUS & LEDERER PARTGMBBADMISSIBLE

Patent Citations (30) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS20080109983
DESCRIPTIONWO2007US61521
DESCRIPTIONWO2008US61579
DESCRIPTIONUS6645527
EXAMINATIONWO2008134512
INTERNATIONAL-SEARCH-REPORTWO2004098617
INTERNATIONAL-SEARCH-REPORTWO2012145491
INTERNATIONAL-SEARCH-REPORTWO9600074
OPPOSITIONDE19536387
OPPOSITIONDE2224534
OPPOSITIONEP0116755
OPPOSITIONEP0157695
OPPOSITIONEP0413828
OPPOSITIONEP0548448
OPPOSITIONEP0631781
OPPOSITIONEP2478909
OPPOSITIONJP2893140B
OPPOSITIONWO03059358
OPPOSITIONWO2004098507
OPPOSITIONWO2006018119
OPPOSITIONWO2006094782
OPPOSITIONWO2007092755
OPPOSITIONWO2008008608
OPPOSITIONWO2008134512
OPPOSITIONWO2009101131
OPPOSITIONWO2009101136
OPPOSITIONWO2012163836
OPPOSITIONWO9116899
OPPOSITIONWO9209271
OPPOSITIONWO9901111

Non-Patent Literature (NPL) Citations (12) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- "United States Pharmacopeia", USP 29-NF 24, Dissolution <711> physical tests and determinations, UNITED STATES PHARMACOPEIAL CONVENTION, INC., (2006), pages 2673 - 2682
DESCRIPTION- USP 29-NF 24, Dissolution <711> physical tests and determinations, UNITED STATES PHARMACOPEIAL CONVENTION, INC., (2006), pages 2673 - 2682
INTERNATIONAL-SEARCH-REPORT- RAPURI P B ET AL, "Effect of vitamins D2 and D3 supplement use on serum 25OHD concentration in elderly women in summer and winter", CALCIFIED TISSUE INTERNATIONAL, NEW YORK, NY, US, (20040201), vol. 74, no. 2, doi:10.1007/S00223-003-0083-8, ISSN 0171-967X, pages 150 - 156, XP002454820 [A] 1-73 * the whole document *
OPPOSITION- Anonymous, "Hydroxypropyl Cellulose", Anonymous, Raymond C Rowe; Paul J Sheskey; Marian E Quinn (eds.), Handbook of Pharmaceutical Excipients, UK , Pharmaceutical Press , (20090101), pages 317 - 329, ISBN 978-0-85369-792-3, XP093096100
OPPOSITION- Anonymous, "Passage;The Theory and Practice of Industrial Pharmacy", Anonymous, Herbert A. Lieberman, Joseph L. Kanig, The Theory and Practice of Industrial Pharmacy, (19870101), pages 189 - 189, ISBN 0-8121-0977-2, XP093139784
OPPOSITION- Levina Marina, "Influence of Fillers, Compression Force, Film Coatings & Storage Conditions on performance of Hypromellose Matrices", Drug delivery Technology, (20240101), vol. 4, no. 1, pages 1 - 5, XP093138199
OPPOSITION- Jannin, V. Musakhanian, J. Marchaud, D., "Approaches for the development of solid and semi-solid lipid-based formulations", Advanced Drug Delivery Reviews, Elsevier, Amsterdam , NL, Amsterdam , NL , (20071104), vol. 60, no. 6, doi:10.1016/j.addr.2007.09.006, ISSN 0169-409X, pages 734 - 746, XP022476861
OPPOSITION- Chambin O, Jannin V, Champion D, Chevalier C, Rochat-Gonthier M.-H, Pourcelot Y, "Influence of cryogenic grinding on properties of a self-emulsifying formulation", International Journal of Pharmaceutics, ELSEVIER, NL, NL , (20040601), vol. 278, no. 1, doi:10.1016/j.ijpharm.2004.02.033, ISSN 0378-5173, pages 79 - 89, XP055961202
OPPOSITION- Jannin Vincent; Cuppok Yvonne, "Hot-melt coating with lipid excipients", International Journal of Pharmaceutics, ELSEVIER, NL, NL , (20121023), vol. 457, no. 2, doi:10.1016/j.ijpharm.2012.10.026, ISSN 0378-5173, pages 480 - 487, XP028779490
OPPOSITION- Jannin Vincent, "Lauroyl polyoxylglycerides, functionalized coconut oil, enhancing the bioavailability of poorly soluble active substances", RIFT Applicability; draft-ietf-rift-applicability-00.txt; INTERNET-DRAFT: RIFT WG, Internet Engineering Task Force, IETF; StandardWorkingDraft, Internet Society (ISOC) 4, rue des Falaises CH- 1205 Geneva, Switzerland, Internet Society (ISOC) 4, rue des Falaises CH- 1205 Geneva, Switzerland , (20090701), vol. 16, no. 4-5-6, doi:10.1051/ocl.2009.0270, ISSN 1258-8210, pages 267 - 272, XP055961199
OPPOSITION- Vueba M. L., Batista De Carvalho L. A. E., Veiga F., Sousa J. J., Pina Maria Eugénia, "Role of Cellulose Ether Polymers on Ibuprofen Release from Matrix Tablets", Journal Drug Development and Industrial Pharmacy, NEW YORK, NY, US, US , (20050801), vol. 31, no. 7, doi:10.1080/03639040500216360, ISSN 0363-9045, pages 653 - 665, XP055821069
OPPOSITION- Ali Nokhodchi, Shaista Raja, Pryia Patel, Kofi Asare-Addo, "The Role of Oral Controlled Release Matrix Tablets in Drug Delivery Systems", BioImpacts, Tabriz University of Medical Sciences, doi:10.5681/bi.2012.027, (20120101), pages 175 - 187, BioImpacts, URL: http://dx.doi.org/10.5681/bi.2012.027, XP055216956

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents